Verition Fund Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-102,843
| Closed | -$157K | – | 2753 |
|
|
2024
Q4 | $157K | Sell |
102,843
-5,272
| -5% | -$8.07K | ﹤0.01% | 2363 |
|
|
2024
Q3 | $215K | Buy |
108,115
+83,542
| +340% | +$166K | ﹤0.01% | 2156 |
|
|
2024
Q2 | $86K | Buy |
+24,573
| New | +$86K | ﹤0.01% | 2094 |
|
|
2020
Q1 | – | Sell |
-10,626
| Closed | -$250K | – | 713 |
|
|
2019
Q4 | $250K | Buy |
+10,626
| New | +$250K | ﹤0.01% | 766 |
|
|
2018
Q4 | – | Sell |
-6,581
| Closed | -$208K | – | 943 |
|
|
2018
Q3 | $208K | Buy |
+6,581
| New | +$208K | 0.01% | 1083 |
|